Cargando…

FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis

Forkhead box protein O3 (FOXO3) has good inhibition ability toward fibroblast activation and extracellular matrix, especially for the treatment of idiopathic pulmonary fibrosis. How FOXO3 regulates pulmonary fibrosis remains unclear. In this study, we reported that FOXO3 had binding sequences with F...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hailong, Li, Jinhe, Hu, Yayue, Zhang, Ruotong, Gu, Xiaoting, Wei, Yiying, Zhang, Shanshan, Chen, Xuefen, Wei, Luqing, Li, Xiaohe, Gu, Songtao, Jin, Jin, Huang, Hui, Zhou, Honggang, Yang, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321294/
https://www.ncbi.nlm.nih.gov/pubmed/37416778
http://dx.doi.org/10.7150/ijbs.80140
_version_ 1785068594859606016
author Li, Hailong
Li, Jinhe
Hu, Yayue
Zhang, Ruotong
Gu, Xiaoting
Wei, Yiying
Zhang, Shanshan
Chen, Xuefen
Wei, Luqing
Li, Xiaohe
Gu, Songtao
Jin, Jin
Huang, Hui
Zhou, Honggang
Yang, Cheng
author_facet Li, Hailong
Li, Jinhe
Hu, Yayue
Zhang, Ruotong
Gu, Xiaoting
Wei, Yiying
Zhang, Shanshan
Chen, Xuefen
Wei, Luqing
Li, Xiaohe
Gu, Songtao
Jin, Jin
Huang, Hui
Zhou, Honggang
Yang, Cheng
author_sort Li, Hailong
collection PubMed
description Forkhead box protein O3 (FOXO3) has good inhibition ability toward fibroblast activation and extracellular matrix, especially for the treatment of idiopathic pulmonary fibrosis. How FOXO3 regulates pulmonary fibrosis remains unclear. In this study, we reported that FOXO3 had binding sequences with F-spondin 1 (SPON1) promoter, which can activate its transcription and selectively promote the expression of SPON1 circRNA (circSPON1) but not mRNA expression. We further demonstrated that circSPON1 was involved in the extracellular matrix deposition of HFL1. In the cytoplasm, circSPON1 directly interacted with TGF-β1-induced Smad3 and inhibited the activation of fibroblasts by inhibiting nuclear translocation. Moreover, circSPON1 bound to miR-942-5p and miR-520f-3p that interfered with Smad7 mRNA and promoted Smad7 expression. This study revealed the mechanism of FOXO3-regulated circSPON1 in the development of pulmonary fibrosis. Potential therapeutic targets and new insights into the diagnosis and treatment of idiopathic pulmonary fibrosis based on circRNA were also provided.
format Online
Article
Text
id pubmed-10321294
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-103212942023-07-06 FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis Li, Hailong Li, Jinhe Hu, Yayue Zhang, Ruotong Gu, Xiaoting Wei, Yiying Zhang, Shanshan Chen, Xuefen Wei, Luqing Li, Xiaohe Gu, Songtao Jin, Jin Huang, Hui Zhou, Honggang Yang, Cheng Int J Biol Sci Research Paper Forkhead box protein O3 (FOXO3) has good inhibition ability toward fibroblast activation and extracellular matrix, especially for the treatment of idiopathic pulmonary fibrosis. How FOXO3 regulates pulmonary fibrosis remains unclear. In this study, we reported that FOXO3 had binding sequences with F-spondin 1 (SPON1) promoter, which can activate its transcription and selectively promote the expression of SPON1 circRNA (circSPON1) but not mRNA expression. We further demonstrated that circSPON1 was involved in the extracellular matrix deposition of HFL1. In the cytoplasm, circSPON1 directly interacted with TGF-β1-induced Smad3 and inhibited the activation of fibroblasts by inhibiting nuclear translocation. Moreover, circSPON1 bound to miR-942-5p and miR-520f-3p that interfered with Smad7 mRNA and promoted Smad7 expression. This study revealed the mechanism of FOXO3-regulated circSPON1 in the development of pulmonary fibrosis. Potential therapeutic targets and new insights into the diagnosis and treatment of idiopathic pulmonary fibrosis based on circRNA were also provided. Ivyspring International Publisher 2023-06-12 /pmc/articles/PMC10321294/ /pubmed/37416778 http://dx.doi.org/10.7150/ijbs.80140 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Li, Hailong
Li, Jinhe
Hu, Yayue
Zhang, Ruotong
Gu, Xiaoting
Wei, Yiying
Zhang, Shanshan
Chen, Xuefen
Wei, Luqing
Li, Xiaohe
Gu, Songtao
Jin, Jin
Huang, Hui
Zhou, Honggang
Yang, Cheng
FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis
title FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis
title_full FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis
title_fullStr FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis
title_full_unstemmed FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis
title_short FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis
title_sort foxo3 regulates smad3 and smad7 through spon1 circular rna to inhibit idiopathic pulmonary fibrosis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321294/
https://www.ncbi.nlm.nih.gov/pubmed/37416778
http://dx.doi.org/10.7150/ijbs.80140
work_keys_str_mv AT lihailong foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT lijinhe foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT huyayue foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT zhangruotong foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT guxiaoting foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT weiyiying foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT zhangshanshan foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT chenxuefen foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT weiluqing foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT lixiaohe foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT gusongtao foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT jinjin foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT huanghui foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT zhouhonggang foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis
AT yangcheng foxo3regulatessmad3andsmad7throughspon1circularrnatoinhibitidiopathicpulmonaryfibrosis